The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add ...

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

StockNews.com assumed coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical equipment provider’s stock.

Globus intends to discuss the expected benefits of the expanded product offerings in its first quarter earnings conference. Credit: T Schneider / Shutterstock. Globus Medical has completed its ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro. In February, Audobon, Pennsylvania-based Globus agreed to acquire all shares of ...